BREAKING: Pfizer Announces $1.7 Billion in Severance Packages

With the BIOSECURE ACT being thwarted, Pfizer is decoupling from the US and European employment markets by moving their business investments and partnerships elsewhere, i.e. China.

May 24, 2024

∙ Paid

May 23, 2024: With the BIOSECURE ACT being thwarted, American BioPharma companies are no longer worried about having their access to fast and cheap manufacturing out of China cut anytime soon.

BREAKING: Pfizer Announces $1.7 Billion in Severance Packages

With the BIOSECURE ACT being thwarted, Pfizer is decoupling from the US and European employment markets by moving their business investments and partnerships elsewhere, i.e. China.

This post is for paid subscribers